Gefitinib

In the US, Gefitinib (gefitinib systemic) is a member of the drug class EGFR inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

• Gefitinib

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE02

CAS registry number (Chemical Abstracts Service)

0184475-35-2

Chemical Formula

C22-H24-Cl-F-N4-O3

Molecular Weight

446

Therapeutic Category

Antineoplastic agent

Chemical Names

4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholin)propoxy]- (USAN)

N-(3-Chlor-4-fluorphenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]chinazolin-4-amin (IUPAC)

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine (WHO)

Foreign Names

• Gefitinibum (Latin)
• Gefitinib (German)
• Gefitinib (French)
• Gefitinib (Spanish)

Generic Names

• Gefitinib (OS: USAN, BAN)
• ZD 1839 (IS)

Brand Names

• Geftib
  Glenmark, India



• Geftinat
  Natco, India



• Iressa
  AstraZeneca, Argentina; AstraZeneca, Austria; AstraZeneca, Australia; AstraZeneca, Bahrain; AstraZeneca, Canada; AstraZeneca, Switzerland; AstraZeneca, Chile; AstraZeneca, China; AstraZeneca, Germany; AstraZeneca, Spain; AstraZeneca, France; AstraZeneca, United Kingdom; AstraZeneca, Georgia; AstraZeneca, Greece; AstraZeneca, Hong Kong; AstraZeneca, Indonesia; AstraZeneca, Israel; AstraZeneca, Japan; AstraZeneca, Mexico; AstraZeneca, Malaysia; AstraZeneca, New Zealand; AstraZeneca, Philippines; AstraZeneca, Serbia; AstraZeneca, Russian Federation; AstraZeneca, Singapore; AstraZeneca, Thailand; AstraZeneca, Taiwan; AstraZeneca, United States



• IRESSA
  AstraZeneca, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.